dbo:abstract |
Omadacyclin (früher PTK-0796) Ist ein Breitspektrum-Antibiotikum aus der Gruppe der Tetracycline, welches intravenös oder in Tablettenform verabreicht werden kann. Chemisch ist es ein Aminomethylcyclin In den USA wurde es von der FDA am 3. Oktober 2018 unter den Namen Nuzyra für die Behandlung einer ambulant erworbenen Lungenentzündung (Englisch: community-acquired pneumonia, CAP) und für akute Haut- und Bindegewebsinfektionen zugelassen. (de) L'omadacycline est un antibiotique de la classe des tétracyclines. (fr) Omadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. (en) Омадациклин — полусинтетический антибиотик группы тетрациклинов (подкласс аминометилциклинов) широкого спектра действия. Одобрен для применения: США (2018). (ru) |
dbo:alternativeName |
Nuzyra (en) |
dbo:casNumber |
389139-89-3 |
dbo:chEMBL |
1689772 |
dbo:drugbank |
DB12455 |
dbo:fdaUniiCode |
090IP5RV8F |
dbo:kegg |
D09647 D09940 |
dbo:medlinePlus |
a618066 |
dbo:pubchem |
54697325 |
dbo:thumbnail |
wiki-commons:Special:FilePath/Omadacycline.svg?width=300 |
dbo:wikiPageExternalLink |
https://medlineplus.gov/druginfo/meds/a618067.html https://druginfo.nlm.nih.gov/drugportal/name/omadacycline https://druginfo.nlm.nih.gov/drugportal/name/omadacycline%20tosylate |
dbo:wikiPageID |
40306838 (xsd:integer) |
dbo:wikiPageLength |
14170 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1090379384 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Sarecycline dbr:Methicillin-resistant_Staphylococcus_aureus dbr:Ribosomal_protein dbr:Urinary_tract_infection dbr:In_vitro dbr:In_vivo dbr:Oral_administration dbr:Moxifloxacin dbr:Phase_II_study dbr:Protein_synthesis dbr:Legionella dbr:Linezolid dbc:Tetracycline_antibiotics dbr:Mark_L._Nelson dbr:Gram-negative dbr:Gram-positive dbr:FDA dbr:Food_and_Drug_Administration_Safety_and_Innovation_Act dbr:Streptococcus_pneumoniae dbr:Chlamydia dbr:Efflux_(microbiology) dbr:Tetracycline_antibiotics dbr:Skin_and_skin_structure_infection dbr:Vancomycin-resistant_Enterococcus dbr:Intravenous dbr:Broad_spectrum_antibiotic dbr:Community-acquired_bacterial_pneumonia |
dbp:atcPrefix |
J01 (en) |
dbp:atcSuffix |
AA15 (en) |
dbp:c |
29 (xsd:integer) |
dbp:casNumber |
389139 (xsd:integer) |
dbp:chembl |
1689772 (xsd:integer) |
dbp:chemspiderid |
20131003 (xsd:integer) |
dbp:dailymedid |
Omadacycline (en) |
dbp:drugbank |
DB12455 (en) |
dbp:h |
40 (xsd:integer) |
dbp:index2Label |
as salt (en) |
dbp:kegg |
D09647 (en) D09940 (en) |
dbp:legalUs |
Rx-only (en) |
dbp:medlineplus |
a618066 (en) |
dbp:n |
4 (xsd:integer) |
dbp:o |
7 (xsd:integer) |
dbp:pronounce |
oh mad" a sye' kleen (en) |
dbp:pubchem |
54697325 (xsd:integer) |
dbp:routesOfAdministration |
dbr:Oral_administration dbr:Intravenous |
dbp:smiles |
CCCNCc1ccNC (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
JEECQCWWSTZDCK-IQZGDKDPSA-N (en) |
dbp:synonyms |
PTK-0796, BAY 73-6944 (en) |
dbp:tradename |
Nuzyra (en) |
dbp:unii |
90 (xsd:integer) |
dbp:wikiPageUsesTemplate |
dbt:Cite_web dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:TetracyclineAntiBiotics dbt:ATC dbt:Drugs.com |
dct:subject |
dbc:Tetracycline_antibiotics |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAntibiotics yago:Agent114778436 yago:Antibacterial102716205 yago:Antibiotic102716866 yago:CausalAgent100007347 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090 |
rdfs:comment |
Omadacyclin (früher PTK-0796) Ist ein Breitspektrum-Antibiotikum aus der Gruppe der Tetracycline, welches intravenös oder in Tablettenform verabreicht werden kann. Chemisch ist es ein Aminomethylcyclin In den USA wurde es von der FDA am 3. Oktober 2018 unter den Namen Nuzyra für die Behandlung einer ambulant erworbenen Lungenentzündung (Englisch: community-acquired pneumonia, CAP) und für akute Haut- und Bindegewebsinfektionen zugelassen. (de) L'omadacycline est un antibiotique de la classe des tétracyclines. (fr) Omadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. (en) Омадациклин — полусинтетический антибиотик группы тетрациклинов (подкласс аминометилциклинов) широкого спектра действия. Одобрен для применения: США (2018). (ru) |
rdfs:label |
Omadacyclin (de) Omadacycline (fr) Omadacycline (en) Омадациклин (ru) |
owl:sameAs |
freebase:Omadacycline yago-res:Omadacycline wikidata:Omadacycline dbpedia-de:Omadacycline dbpedia-fa:Omadacycline dbpedia-fr:Omadacycline dbpedia-ru:Omadacycline dbpedia-sh:Omadacycline dbpedia-sr:Omadacycline dbpedia-vi:Omadacycline https://global.dbpedia.org/id/YM3P |
prov:wasDerivedFrom |
wikipedia-en:Omadacycline?oldid=1090379384&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Omadacycline.svg |
foaf:isPrimaryTopicOf |
wikipedia-en:Omadacycline |
is dbo:wikiPageRedirects of |
dbr:Nuzyra dbr:Omadacycline_tosylate |
is dbo:wikiPageWikiLink of |
dbr:List_of_antibiotics dbr:Antibiotic dbr:Nuzyra dbr:Mark_L._Nelson dbr:ATC_code_J01 dbr:Tetracycline_antibiotics dbr:List_of_drugs:_O–Op dbr:Omadacycline_tosylate |
is foaf:primaryTopic of |
wikipedia-en:Omadacycline |